Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer

Nicola Baldini, Angelo De Milito, Olivier Feron, Robert J. Gillies, Carine Michiels, Angela M. Otto, Silvia Pastoreková, Stine F. Pedersen, Paolo E. Porporato, Pierre Sonveaux, Claudiu T. Supuran, Sofia Avnet

Research output: Contribution to journalArticle

Abstract

Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

LanguageEnglish
Article number411
Number of pages5
JournalFrontiers in Pharmacology
Volume8
Issue numberJUL
DOIs
StatePublished - 2017

Fingerprint

Metabolic Networks and Pathways
Neoplasms
Therapeutics
Precision Medicine
Belgium
Energy Metabolism
Recurrence
Food

Keywords

  • Cancer imaging
  • Cancer therapy
  • Proton dynamics
  • Tumor metabolism
  • Tumor microenvironment

Cite this

Baldini, Nicola ; De Milito, Angelo ; Feron, Olivier ; Gillies, Robert J. ; Michiels, Carine ; Otto, Angela M. ; Pastoreková, Silvia ; Pedersen, Stine F. ; Porporato, Paolo E. ; Sonveaux, Pierre ; Supuran, Claudiu T. ; Avnet, Sofia. / Annual meeting of the International Society of Cancer Metabolism (ISCaM) : Metabolic networks in cancer. In: Frontiers in Pharmacology. 2017 ; Vol. 8, No. JUL.
@article{b5915798c4624e74bcbdc388202a0822,
title = "Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer",
abstract = "Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.",
keywords = "Cancer imaging, Cancer therapy, Proton dynamics, Tumor metabolism, Tumor microenvironment",
author = "Nicola Baldini and {De Milito}, Angelo and Olivier Feron and Gillies, {Robert J.} and Carine Michiels and Otto, {Angela M.} and Silvia Pastorekov\{'a} and Pedersen, {Stine F.} and Porporato, {Paolo E.} and Pierre Sonveaux and Supuran, {Claudiu T.} and Sofia Avnet",
year = "2017",
doi = "10.3389/fphar.2017.00411",
language = "English",
volume = "8",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "JUL",

}

Baldini, N, De Milito, A, Feron, O, Gillies, RJ, Michiels, C, Otto, AM, Pastoreková, S, Pedersen, SF, Porporato, PE, Sonveaux, P, Supuran, CT & Avnet, S 2017, 'Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer' Frontiers in Pharmacology, vol 8, no. JUL, 411. DOI: 10.3389/fphar.2017.00411

Annual meeting of the International Society of Cancer Metabolism (ISCaM) : Metabolic networks in cancer. / Baldini, Nicola; De Milito, Angelo; Feron, Olivier; Gillies, Robert J.; Michiels, Carine; Otto, Angela M.; Pastoreková, Silvia; Pedersen, Stine F.; Porporato, Paolo E.; Sonveaux, Pierre; Supuran, Claudiu T.; Avnet, Sofia.

In: Frontiers in Pharmacology, Vol. 8, No. JUL, 411, 2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Annual meeting of the International Society of Cancer Metabolism (ISCaM)

T2 - Frontiers in Pharmacology

AU - Baldini,Nicola

AU - De Milito,Angelo

AU - Feron,Olivier

AU - Gillies,Robert J.

AU - Michiels,Carine

AU - Otto,Angela M.

AU - Pastoreková,Silvia

AU - Pedersen,Stine F.

AU - Porporato,Paolo E.

AU - Sonveaux,Pierre

AU - Supuran,Claudiu T.

AU - Avnet,Sofia

PY - 2017

Y1 - 2017

N2 - Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

AB - Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

KW - Cancer imaging

KW - Cancer therapy

KW - Proton dynamics

KW - Tumor metabolism

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85025467140&partnerID=8YFLogxK

U2 - 10.3389/fphar.2017.00411

DO - 10.3389/fphar.2017.00411

M3 - Article

VL - 8

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - JUL

M1 - 411

ER -